Shamir Optical Industry was formed in Israel in 1972 and has subsequently spread to over 50 nations worldwide. The company employs over 2,000 employees and has various cutting-edge manufacturing sites across the world.

Shamir Optical Industry provides a wide range of lens designs with innovative features such as digital surfacing, progressive surface optimization, and personalized design for the highest visual acuity and comfort. The products of the company are designed to improve patients' visual performance, reduce eye strain, and increase comfort.

Shamir Optical Industry also offers software solutions, such as Eye-Point Technology, which uses complex algorithms to enhance lens performance based on the patient's particular demands. In addition, the company provides its customers with training and support to guarantee that they can use its goods and services efficiently.

Shamir Optical Industry is devoted to sustainability and decreasing its environmental effect. The company has adopted a number of initiatives to reduce waste, reduce energy use, and promote recycling.

Shamir Optical Industry recorded revenue of approximately USD 719.6 million in fiscal year 2023. The company's financial performance is stable with increasing revenue and net profit and has a strong direction for future growth.

Founded: 1972
Headquarters: Kibbutz Shamir, Upper Galilee, Northern District, 1213500, Israel
Website: https://shamir.com/for-professionals

InMode is a medical technology firm that designs, develops, manufactures, and markets medical solutions that use energy. The products of the company are utilized in minimally invasive aesthetic and medical operations. InMode provides a comprehensive range of innovative solutions for surgical, non-surgical, and minimally invasive face and body treatments. BodyTite, FaceTite, Morpheus8, Evoke, and AccuTite are some of their most popular items.

Radiofrequency technology is used in these items to send precise, regulated energy to specific parts of the body, resulting in better skin tone, texture, and contouring. InMode is headquartered in Israel and maintains offices in the United States, Europe, Asia, and Latin America.

BodyTite is one of InMode's most popular products. Radiofrequency-assisted liposuction (RFAL) is used in this gadget to remove excess fat and tighten the skin. BodyTite can be applied to virtually any portion of the body, including the abdomen, thighs, arms, and back. FaceTite, another popular product, uses the same RFAL technology to tighten skin and decrease the appearance of wrinkles on the face and neck.

The Morpheus8 by InMode is a fractional radiofrequency device that can be used to improve skin texture, eliminate fine lines and wrinkles, and stimulate collagen formation. Evoke is a non-invasive facial remodeling technology that tightens the skin and improves facial shapes by using radiofrequency energy. AccuTite is a minimally invasive device for treating tiny areas of the face and body, such as the chin and jowls.

Inmode reported revenue of $227.8 million in 2020, an increase of 16.7% from the year before. The business's net income increased 1.3% from the prior year to $70.6 million. Additionally, the business reported having $154.3 million in cash on hand and no long-term debt. InMode announced earnings of about $431.2 million for the 2023 fiscal year.

Founded: 2008

Headquarters: Tavor Building Sha'ar Yokneam PO Box 533, Yokneam, Isreal

Website: https://inmodemd.com/

Lumenis is a global leader in medical and aesthetic lasers, as well as energy-based technology. The company creates and manufactures a variety of cutting-edge products and solutions for surgical, ophthalmic, aesthetic, and veterinary purposes. Lumenis was founded in 1966 and is headquartered in Yokneam, Israel, with operations in over 100 locations worldwide.

The UltraPulse CO2 laser, the LightSheer diode laser for hair removal, and the M22 IPL platform for skin rejuvenation and vascular lesions are among their most well-known products.

Indeed, the business is credited with developing the first CO2 surgical laser more than 50 years ago. Lumenis has continued to create new technologies and products to satisfy the changing demands of healthcare practitioners and patients since then.

Today, the company provides a diverse range of medical and aesthetic products and solutions. Laser systems for surgical and ophthalmic operations, as well as energy-based devices for non-invasive aesthetic treatments including hair removal, skin rejuvenation, and body contouring, are examples of these. Lumenis also offers training and assistance to help healthcare providers get the most out of their devices.

Lumenis has a presence in the veterinary sector in addition to its medical and aesthetic businesses. The company provides a variety of laser and energy-based animal healthcare treatments, including surgical and dental procedures.

Lumenis announced revenue of roughly $351 million for the fiscal year 2023. Lumenis is a global leader in the medical and aesthetic laser markets, with a solid reputation for innovation, quality, and customer service.

Founded: 1966
Headquarters: 6 Hakidma, Yokneam, North District, 2069204, Israel
Website: https://lumenis.com/

Eldan Electronic Instruments was established in 1960 and is based in Jerusalem, Israel. Since its founding, the company has been focused on developing creative solutions for its client's needs in the scientific and medical.

While Eldan Electronic Instruments' primary focus has been on scientific research and industrial uses, they do offer certain items that can be utilized in medical applications. They provide a high-precision power supply, for example, that can be utilized in medical equipment such as MRI machines and X-ray systems. They also provide signal generators and oscilloscopes for the development of medical devices such as pacemakers and defibrillators.

Eldan Electronic Instruments has also worked with medical equipment makers to create tailored solutions for their specific needs. They have an engineering team that can collaborate closely with medical device makers to design and produce electronic instruments that match their specific needs.

For the fiscal year 2023, Eldan Electronic Instruments reported revenue of around $225.6 million. Corporate revenue increased significantly until 2023, and Eldan Electronic Instruments while not particularly focused on the medical industry, has a number of products and capabilities that can be applied to medical applications both at home and abroad.

Founded: 1960
Headquarters: Hashiloach St, Petach-Tikva, 4951439, Israel
Website: https://eldanmi.com/about/eldan

Kobi Vortman and Maurice R. Ferré launched INSIGHTEC in 1999, and it has since become a leader in the field of non-invasive surgical technology. Their Exablate device ablates tissue deep inside the body using high-intensity focused ultrasound (HIFU) without the need for incisions or invasive surgery. This technique is especially effective for addressing illnesses that are difficult to access or need invasive surgery in the past.

Exablate, a non-invasive, targeted ultrasound technology that can be used to treat illnesses such as uterine fibroids, essential tremors, and bone metastases, is their main product. The company's headquarters are in Haifa, Israel, and it has offices and operations all around the world. In addition to the Exablate system, INSIGHTEC has created other medical technologies, such as a transcranial magnetic resonance imaging (MRI) compatible focused ultrasound system for the treatment of neurological disorders and a magnetic resonance imaging (MRI) compatible robotic system for use in minimally invasive surgeries.

INSIGHTEC reported revenue of roughly $100.3 million for the fiscal year 2023. INSIGHTEC has garnered multiple honors and recognitions for its breakthrough technology, including being named one of Fast Company's 2018 World's Most Breakthrough Companies. They have also gained regulatory certifications from organizations such as the US Food and Drug Administration (FDA) and the European CE Mark for their products.

Founded: 1999
Headquarters: 5 Nachum Heth St, Tirat Carmel, Haifa, Israel
Website: https://insightec.com/

Itamar Medical is a medical technology firm that develops and commercializes non-invasive diagnosis and monitoring devices for sleep apnea and other sleep-related illnesses. The company was established in 1997 and is based in Caesarea, Israel.

The WatchPAT system, which is a wrist-worn device that uses peripheral arterial tone (PAT) technology to detect and diagnose sleep apnea, is Itamar Medical's flagship product. The WatchPAT system is a non-invasive alternative to traditional sleep studies that can be utilized in the patient's own home.

Itamar Medical, in addition to the WatchPAT system, provides various other solutions for diagnosing and monitoring sleep apnea and related diseases. These include the EndoPAT system, which assesses cardiovascular risk by measuring endothelial function, and the SleePath system, a cloud-based platform for the care of sleep apnea sufferers.

Itamar Medical has won multiple awards and accolades for its revolutionary technology, including being designated a Red Herring Top 100 Global Firm in 2017 and a Fast Firm Most Revolutionary Company in 2020. They have also gained regulatory certifications from organizations such as the US Food and Drug Administration (FDA) and the European CE Mark for their products.

Itamar Medical's most current financial report, which is publicly available, contains information about the company's financial performance. According to that report, the company's sales in 2020 were $49.7 million, up 16.6% from the previous year. Compared to a net loss of $0.9 million in 2019, the company's net income in 2020 was $6.2 million. As of August 2021, Itamar Medical's market value was roughly $1.3 billion. For the fiscal year 2023, Itamar Medical recorded revenue of about $50.9 million.

Founded: 1997
Headquarters: 9 Halamish St, Caesarea, 3088900, Israel
Website: https://www.itamar-medical.com/global-presence/

A group of scientists, engineers, and entrepreneurs launched Sight Diagnostics in 2011. The company's headquarters are in Israel, but it also maintains operations in the United States. The OLO platform has acquired regulatory approval in Europe, the United States, and other countries and is now being utilized in hospitals and clinics worldwide.

Sight Diagnostics is a medical technology firm that has created the OLO AI-powered blood analysis tool. With just two drops of blood, this platform can produce full blood count (CBC) results in minutes. The platform analyzes blood samples using digital microscopy and AI algorithms, offering quick and reliable results that can help clinicians make informed treatment decisions. The technology developed by Sight Diagnostics has the potential to transform the way blood tests are currently performed, making them faster, more accurate, and more accessible to patients.

Sight Diagnostics has created a digital pathology platform called Path in addition to its blood analysis platform. This platform uses AI algorithms to evaluate tissue samples and deliver accurate cancer and other disease diagnosis.

Founded: 2011
Headquarters: Jerusalem Technology Park, Jerusalem, Jerusalem, Israel
Website: https://sightdx.com/en-us

Shl Telemedicine, which was formed in 1987, has developed to become a significant provider of remote medical diagnostic and monitoring services. The company's solutions are intended to improve the quality of care, lower costs, and expand access to healthcare for people worldwide.

Healthcare practitioners, hospitals, and clinics all across the world use Shl Telemedicine's telemedicine services. The company's telemedicine solutions provide remote diagnosis, consultation, and treatment as well as real-time access to medical expertise. Shl Telemedicine's solutions are also employed in clinical trials and research investigations, where they provide remote monitoring and data collection.

Shl Telemedicine, in addition to its telemedicine solutions, provides medical devices and software platforms for remote monitoring of vital indicators such as blood pressure, glucose levels, and heart rate. Patients utilize these devices and platforms at home to communicate data to healthcare experts for remote monitoring and management.

Shl Telemedicine is a publicly traded company, and its financial information is available to the general public. According to the most current financial report, the company made $31.5 million in revenue in 2020, a 12% increase over the previous year. In 2020, the company made a net profit of $1.9 million, compared to a net loss of $3.1 million in 2019. As of August 2021, its market capitalization was roughly $70 million. Shl Telemedicine announced the fiscal year 2023 revenue of around $49.6 million.

Founded: 1987
Headquarters: 90 Yigal Alon, Tel Aviv, Tel Aviv, 67891, Israel
Website: https://www.shl-telemedicine.com/

BrainsWay was established in 2003 and is based in Jerusalem, Israel. The Deep Transcranial Magnetic Stimulation (Deep TMS) system is the company's main product, and it uses a unique proprietary coil design to activate deeper and larger brain regions than other TMS technologies.

Deep TMS has received regulatory clearance in the United States, Europe, Canada, and Israel for the treatment of depression and OCD, and is currently undergoing clinical trials for other indications such as addiction, PTSD, and Alzheimer's disease. BrainsWay offers training and support to healthcare professionals who use its technology to treat patients in addition to medical devices.

In addition to being selected as a finalist in the 2020 Medical Design Excellence Awards and earning the Innovation of the Year Award at the 2019 Israeli Business Excellence Awards, the company has won acclaim for its revolutionary technologies. BrainsWay is dedicated to furthering neuromodulation research and improving the lives of patients suffering from neurological and psychological diseases.

BrainsWay has reported approximately $31.5 million in sales for fiscal year 2023 and anticipates future growth. BrainsWay specializes in identifying safe and effective remedies for neurological and mental problems through ongoing research and collaboration with recognized medical specialists.

Founded: 2003
Headquarters: 19 Hartum St Bynet Building Har Hotzvim, Jerusalem, Jerusalem, Isreal
Website: https://www.brainsway.com/

Dr. Erez Golan, a pulmonologist and former medical officer in the Israeli Air Force, developed Lumen in 2014. The technique developed by the business is based on the concepts of impulse oscillometry, a non-invasive way of assessing lung function that is widely utilized in research and clinical practice.

The Lumen gadget is intended to be simple to use while yet providing precise and dependable readings of lung function. It measures the resistance and reactance of the respiratory system using a set of sensors and algorithms, which can provide insights into the health of the lungs and airways.

In addition to the Lumen device, the business has created Lumen Cloud, a cloud-based platform that allows healthcare providers to remotely monitor and manage their patient's respiratory health. The platform contains tools for recording symptoms, medication use, and other vital data, and it can be used to develop individualized treatment plans for patients.

Lumen has received funding from a variety of sources, including the Israel Innovation Authority and the European Union's Horizon 2020 initiative. Lumen recorded revenue of around $22.5 million in the fiscal year 2023. The company's products have also acquired regulatory approval in a number of markets throughout the world.

Founded: 2014
Headquarters: 10th floor S Tower Haarba'a St 30 St, Tel Aviv, Tel Aviv, 6107402, Israel
Website: https://www.lumen.me/